Clinical Trial Update: Adjunctive Fludrocortisone in Septic Shock [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating adjunctive fludrocortisone for septic shock is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Fludrocortisone (Fludrocortisone)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Sepsis, Septic Shock | Phase 2 | Status: NOT_YET_RECRUITING